Healio

Bioresorbable scaffold superior to angioplasty for treating chronic limb-threatening ischemia

Please provide your email address to receive an email when new articles are posted on . Researchers randomly assigned 261 patients with chronic limb-threatening ischemia (CLTI) on a 2:1 basis to ...
TCTMD

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

LAS VEGAS, NV—At 2 years, a drug-eluting resorbable scaffold continues to show sustained patency and safety compared with conventional angioplasty alone in patients with below-the-knee (BTK) chronic ...
TCTMD

LIFE-BTK: 3-Year Data Keep Dissolving Scaffold’s Durability Hopes Alive in CLTI

A drug-eluting resorbable scaffold continues to keep many patients with below-the-knee (BTK) chronic limb-threatening ischemia (CLTI) free from repeat procedures, even after most of the device’s ...
Medscape

Drug-Eluting Resorbable Scaffold Beats Angioplasty for Infrapopliteal Artery Disease

San Francisco — An everolimus-eluting stent with a resorbable scaffold showed superior efficacy in a randomized multicenter trial when compared with angioplasty for the treatment of patients with ...
Medscape

Negative Data Piling Up on Absorb Bioresorbable Scaffold

AMSTERDAM, NL — Consistent with prior trials, the risk of scaffold thrombosis was significantly higher in patients receiving the Absorb (Abbott Vascular) bioresorbable vascular scaffold (BVS) than an ...
Healio

Aragonite-based scaffold yielded similar outcomes between men, women with chondral defects

Please provide your email address to receive an email when new articles are posted on . An aragonite-based scaffold for chondral defects had better outcomes vs. microfracture. Women had the same or ...